Revolutionizing Molecular Diagnostics: Sweden

Sweden boasts NGS centers with robust infrastructure and funding support, yet faces challenges in the routine adoption of NGS testing. While possessing the necessary resources, Sweden currently lacks widespread utilization of NGS technology. Notably, the country does not provide reimbursement for NGS or liquid biopsy testing. Despite this, data-sharing practices and security guidelines contribute to a collaborative environment for NGS advancements.

For a more comprehensive understanding, access the complete factsheet using the download button below.

If you like it, share it